Extracorporeal Membrane Oxygenation Machine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component Type, By Modality, By Patient Type, By Application, By Region & Competition, 2021-2031F

Description

The Global Extracorporeal Membrane Oxygenation Machine Market is projected to expand from USD 441.63 Million in 2025 to USD 596.92 Million by 2031, registering a compound annual growth rate of 5.15%. An Extracorporeal Membrane Oxygenation (ECMO) machine functions as a critical life-support apparatus, offering extended respiratory and cardiac assistance to patients with compromised heart and lung function. Market growth is chiefly driven by the increasing incidence of severe cardiovascular and respiratory conditions, such as acute respiratory distress syndrome, coupled with an aging demographic that demands advanced critical care solutions. Data from the Extracorporeal Life Support Organization reveals that by 2024, the registry had cumulatively enrolled more than 200,000 patients, highlighting the broadening adoption of this therapy for life-threatening health issues.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 441.63 Million
Market Size 2031	USD 596.92 Million
CAGR 2026-2031	5.15%
Fastest Growing Segment	Pumps
Largest Market	North America

Despite this robust demand, the market encounters substantial obstacles related to the significant expenses and clinical dangers associated with ECMO interventions, including infection and hemorrhage. When coupled with the requirement for specialized infrastructure and extensive training, these issues form major impediments to widespread adoption, especially in medical facilities lacking significant financial capability or technical proficiency.

Market Driver

The escalating frequency of respiratory and cardiovascular disorders acts as the main engine for growth in the Global Extracorporeal Membrane Oxygenation Machine Market. With the rising occurrence of ailments like acute respiratory distress syndrome and heart failure, the clinical requirement for mechanical circulatory support is becoming increasingly urgent. The impact is significant; the American Heart Association's 'Heart Disease and Stroke Statistics-2024 Update' from January 2024 reveals that approximately 48.6% of adults in the United States suffer from some type of cardiovascular disease. This reality forces healthcare institutions to adopt sophisticated life-support systems to treat this expanding patient demographic, thereby stimulating the need for ECMO as a crucial bridge to transplantation or recovery.

Concurrently, market momentum is being sustained by the growing implementation of extracorporeal cardiopulmonary resuscitation and the broadening of specialized critical care facilities. This upward trend is mirrored in the financial results of key market participants, indicating a general increase in device usage. For example, LivaNova reported in its 'First Quarter 2024 Results' in May 2024 that revenue for its Cardiopulmonary division rose by 14.8% year-over-year, demonstrating the rapid adoption of these treatments. This expansion is further supported by broader industry figures; Terumo Corporation's 'Consolidated Financial Results for the Fiscal Year Ended March 31, 2024', released in May 2024, showed a 12.4% annual increase in total revenue, emphasizing the substantial commercial scale and ongoing investment in these essential care technologies.

Market Challenge

The significant financial expenses and considerable clinical dangers linked to Extracorporeal Membrane Oxygenation procedures act as major impediments to the global market's expansion. Medical centers must contend with heavy costs, not only for the initial purchase of these sophisticated devices but also for the continuous funding required for specialized facilities and highly skilled multidisciplinary teams. These economic barriers effectively prevent resource-constrained or smaller healthcare institutions from adopting the technology, consequently limiting the market's potential client base primarily to large medical hubs.

Additionally, the frequency of severe complications restricts the use of this therapy to a measure of last resort rather than a standard option. The volatility of clinical outcomes is underscored by recent data showing the challenges in securing survival among high-risk patient cohorts. As per the Registry International Report released by the Extracorporeal Life Support Organization in 2024, the survival-to-discharge rate for adults undergoing extracorporeal cardiopulmonary resuscitation was merely 29.5 percent. Such modest survival rates solidify the view of the procedure as a precarious undertaking, prompting clinicians to be extremely selective with patients, which ultimately suppresses the global volume of procedures.

Market Trends

The market is undergoing a fundamental transformation due to the development of lightweight, compact transportable ECMO systems, which allow advanced life support to extend beyond stationary tertiary care environments. These miniaturized units enable the safe transfer of critically ill patients between hospitals, effectively implementing a "hub-and-spoke" model where smaller clinics can stabilize patients prior to moving them to specialized facilities. This evolution toward portability resolves the logistical challenges posed by older, bulky consoles, broadening the technology's application in the field and its geographic reach. According to an article by the American College of Surgeons titled 'ECMO Expands from Rare Rescue to Real Option' in September 2025, a survey of U.S. programs indicated that 63 out of 274 adult ECMO centers now provide mobile services, signifying rapid investment in transport infrastructure to enhance patient access.

At the same time, the incorporation of artificial intelligence for real-time predictive analytics is revolutionizing patient care by improving the precision of clinical decisions. Manufacturers are increasingly integrating machine learning algorithms into ECMO devices to interpret complex physiological data, allowing for the early identification of complications like oxygenator failure or clot formation before they reach a critical stage. This technological advancement transitions the therapy from a reactive maintenance approach to a proactive precision medicine strategy, directly addressing the high mortality risks linked to the procedure. This potential was highlighted by Integration Health in their April 2025 report 'AI and ECMO: The Future of Mortality Prediction in Critical Care', which noted that a validated AI model achieved over 93% accuracy in predicting 28-day mortality risk in Veno-Arterial ECMO patients, providing clinicians with a robust tool for optimizing care plans and patient selection.

Key Market Players

India Medtronic Private Limited
Terumo Cardiovascular Systems Corporation
MAQUET Holding B.V. & Co. KG
Medos Medizintechnik AG
Nipro Medical Corporation
MicroPort Scientific Corporation
XENIOS AG
LivaNova PLC
EUROSETS S.r.l.

Report Scope

In this report, the Global Extracorporeal Membrane Oxygenation Machine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extracorporeal Membrane Oxygenation Machine Market, By Component Type

Pumps
Oxygenator
Controllers
Cannula
Accessories

Extracorporeal Membrane Oxygenation Machine Market, By Modality

Veno-Arterial
Veno-Venous
Arterio-Venous

Extracorporeal Membrane Oxygenation Machine Market, By Patient Type

Neonates
Pediatric
Adult

Extracorporeal Membrane Oxygenation Machine Market, By Application

Respiratory
Cardiac
ECPR

Extracorporeal Membrane Oxygenation Machine Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Extracorporeal Membrane Oxygenation Machine Market.

Available Customizations:

Global Extracorporeal Membrane Oxygenation Machine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extracorporeal Membrane Oxygenation Machine Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Component Type (Pumps, Oxygenator, Controllers, Cannula, Accessories)
- 5.2.2. By Modality (Veno-Arterial, Veno-Venous, Arterio-Venous)
- 5.2.3. By Patient Type (Neonates, Pediatric, Adult)
- 5.2.4. By Application (Respiratory, Cardiac, ECPR)
- 5.2.5. By Region
- 5.2.6. By Company (2025)
5.3. Market Map

6. North America Extracorporeal Membrane Oxygenation Machine Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Component Type
- 6.2.2. By Modality
- 6.2.3. By Patient Type
- 6.2.4. By Application
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Component Type
    - 6.3.1.2.2. By Modality
    - 6.3.1.2.3. By Patient Type
    - 6.3.1.2.4. By Application
- 6.3.2. Canada Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Component Type
    - 6.3.2.2.2. By Modality
    - 6.3.2.2.3. By Patient Type
    - 6.3.2.2.4. By Application
- 6.3.3. Mexico Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Component Type
    - 6.3.3.2.2. By Modality
    - 6.3.3.2.3. By Patient Type
    - 6.3.3.2.4. By Application

7. Europe Extracorporeal Membrane Oxygenation Machine Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Component Type
- 7.2.2. By Modality
- 7.2.3. By Patient Type
- 7.2.4. By Application
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Component Type
    - 7.3.1.2.2. By Modality
    - 7.3.1.2.3. By Patient Type
    - 7.3.1.2.4. By Application
- 7.3.2. France Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Component Type
    - 7.3.2.2.2. By Modality
    - 7.3.2.2.3. By Patient Type
    - 7.3.2.2.4. By Application
- 7.3.3. United Kingdom Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Component Type
    - 7.3.3.2.2. By Modality
    - 7.3.3.2.3. By Patient Type
    - 7.3.3.2.4. By Application
- 7.3.4. Italy Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Component Type
    - 7.3.4.2.2. By Modality
    - 7.3.4.2.3. By Patient Type
    - 7.3.4.2.4. By Application
- 7.3.5. Spain Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Component Type
    - 7.3.5.2.2. By Modality
    - 7.3.5.2.3. By Patient Type
    - 7.3.5.2.4. By Application

8. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Component Type
- 8.2.2. By Modality
- 8.2.3. By Patient Type
- 8.2.4. By Application
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Component Type
    - 8.3.1.2.2. By Modality
    - 8.3.1.2.3. By Patient Type
    - 8.3.1.2.4. By Application
- 8.3.2. India Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Component Type
    - 8.3.2.2.2. By Modality
    - 8.3.2.2.3. By Patient Type
    - 8.3.2.2.4. By Application
- 8.3.3. Japan Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Component Type
    - 8.3.3.2.2. By Modality
    - 8.3.3.2.3. By Patient Type
    - 8.3.3.2.4. By Application
- 8.3.4. South Korea Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Component Type
    - 8.3.4.2.2. By Modality
    - 8.3.4.2.3. By Patient Type
    - 8.3.4.2.4. By Application
- 8.3.5. Australia Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Component Type
    - 8.3.5.2.2. By Modality
    - 8.3.5.2.3. By Patient Type
    - 8.3.5.2.4. By Application

9. Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Component Type
- 9.2.2. By Modality
- 9.2.3. By Patient Type
- 9.2.4. By Application
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Component Type
    - 9.3.1.2.2. By Modality
    - 9.3.1.2.3. By Patient Type
    - 9.3.1.2.4. By Application
- 9.3.2. UAE Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Component Type
    - 9.3.2.2.2. By Modality
    - 9.3.2.2.3. By Patient Type
    - 9.3.2.2.4. By Application
- 9.3.3. South Africa Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Component Type
    - 9.3.3.2.2. By Modality
    - 9.3.3.2.3. By Patient Type
    - 9.3.3.2.4. By Application

10. South America Extracorporeal Membrane Oxygenation Machine Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Component Type
- 10.2.2. By Modality
- 10.2.3. By Patient Type
- 10.2.4. By Application
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Component Type
    - 10.3.1.2.2. By Modality
    - 10.3.1.2.3. By Patient Type
    - 10.3.1.2.4. By Application
- 10.3.2. Colombia Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Component Type
    - 10.3.2.2.2. By Modality
    - 10.3.2.2.3. By Patient Type
    - 10.3.2.2.4. By Application
- 10.3.3. Argentina Extracorporeal Membrane Oxygenation Machine Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Component Type
    - 10.3.3.2.2. By Modality
    - 10.3.3.2.3. By Patient Type
    - 10.3.3.2.4. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Extracorporeal Membrane Oxygenation Machine Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. India Medtronic Private Limited
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Terumo Cardiovascular Systems Corporation
15.3. MAQUET Holding B.V. & Co. KG
15.4. Medos Medizintechnik AG
15.5. Nipro Medical Corporation
15.6. MicroPort Scientific Corporation
15.7. XENIOS AG
15.8. LivaNova PLC
15.9. EUROSETS S.r.l.